Article

Weight lifting and lymphedema

Author(s):

In the past, weight lifting has generally been discouraged for breast cancer survivors who have lymphedema. But a recent study, published in The New England Journal of Medicine, reveals that weight lifting may not be so harmful, and actually may benefit survivors.A total of 141 women were randomized for this study with half of the survivors entering a twice-weekly progressive weight-lifting program and half as the control group. Participants were required to wear compression sleeves while weight lifting, trained by certified fitness professionals, and assessed by lymphedema specialists on a regular basis.Researchers concluded, "In breast-cancer survivors with lymphedema, slowly progressive weight lifting had no significant effect on limb swelling and resulted in a decreased incidence of exacerbations of lymphedema, reduced symptoms, and increased strength." Another interesting aspect of this study was the fitness centers used were YMCAs that host the LIVESTRONG program, a collaboration between the Lance Armstrong Foundation and the YMCA to develop programs specifically for cancer survivors and to certify trainers who understand the special needs of survivor population.But before you start pumping iron, make sure you check with your doctor, nurse, or physical therapist to see if you are ready to start a program and find a certified trainer who is trained to work with lymphedema patients and can show you the exercises that will help.

Related Videos
Image of Dr. Salani.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. Suneel Kamath is an assistant professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, in Ohio.
Image of Dr. Fakih.
Dr. Catherine Wu is chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston, Massachusetts.
Dr. John Oertle discusses the key benefits to come from patients with cancer connecting with support networks, advocacy groups and resources.
Dr. Gabriel A. Brooks discussed the recent FDA product labeling update for Xeloda and 5-FU.
1 expert is featured in this series.
Dr. Alan Tan is the GU Oncology Lead at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, as well as an associate professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center and GU Executive Officer with the Alliance for Clinical Trials in Oncology.
Bald Doctor.